Defective astrocytes linked to alpha-synuclein accumulation in Parkinson's

Researchers at the University of Barcelona have found that defects in brain glial cells called astrocytes are linked to the accumulation of alpha-synuclein; a toxic protein that is thought to contribute to Parkinson’s disease.

Nerve cells are affected in ParkinsonAntiv | Shutterstock

The astrocytes, which were derived from patients with Parkinson’s, had a genetic mutation that affects cell clean-up capabilities. Compared with astrocytes from healthy people, the defective astrocytes caused more accumulation of the toxic protein alpha-synuclein.

The finding, which was recently published in the journal Stem Cell Reports, suggests glial cells play a key role in Parkinson’s, potentially providing a new target for the development of therapies.

We have shown that astrocytes play a crucial role in Parkinson's disease. Our results demonstrate that Parkinson's disease astrocytes transfer a toxic protein to dopamine-producing neurons."

Angelique di Domenico, Co-author

Astrocytes are star-shaped glial cells that surround and provide structural support to nerve cells and blood vessels. Previously, a post-mortem study had shown that patients with Parkinson’s have a build-up of alpha-synuclein in their neurons as well as in their astrocytes. The toxic protein accumulates to form aggregates called Lewy bodies – a hallmark of Parkinson’s disease.

This finding led di Domenico and team to assess the role of astrocytes in Parkinson’s.

Seven percent of all inherited and sporadic cases of Parkinson’s are associated with a mutation in a large protein complex called LRRK2, which seems to play a role in the break down and rebuilding of damaged cellular components. Hence, the team took cells from Parkinson’s patients who had an LRRK2 mutation and used them to create stem cell-derived astrocytes.

Using the CRISPR gene editing tool, the team then tracked alpha-synuclein as it was produced by the astrocytes and transferred to dopamine-producing neurons.

We found Parkinson's disease astrocytes to have fragmented mitochondria, as well as several disrupted cellular degradation pathways, leading to the accumulation of alpha-synuclein.”

Angelique di Domenico, Co-author

The build-up of the toxic protein caused the axons and dendrites of targeted neurons to shorten and die. When healthy neurons, on the other hand, were cultured with neurons from Parkinson’s patients, alpha-synuclein did not accumulate and axons and dendrites regenerated, eventually restoring normal neuronal function.

Finally, the team used a drug on the diseased astrocytes that is designed to treat abnormal intracellular accumulation of toxins.

After treatment, the cellular degradation processes were restored and alpha-synuclein was completely eliminated from the Parkinson’s astrocytes.

"These results pave the way to new therapeutic strategies that block pathogenic interactions between neurons and glial cells," di Domenico says.

Next, the team plans to investigate Parkinson’s astrocytes from the 85 to 90 percent of cases that are sporadic and not known to have any genetic foundation.  

Sally Robertson

Written by

Sally Robertson

Sally has a Bachelor's Degree in Biomedical Sciences (B.Sc.). She is a specialist in reviewing and summarising the latest findings across all areas of medicine covered in major, high-impact, world-leading international medical journals, international press conferences and bulletins from governmental agencies and regulatory bodies. At News-Medical, Sally generates daily news features, life science articles and interview coverage.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 20). Defective astrocytes linked to alpha-synuclein accumulation in Parkinson's. News-Medical. Retrieved on October 19, 2019 from https://www.news-medical.net/news/20190110/Defective-astrocytes-linked-to-alpha-synuclein-accumulation-in-Parkinsons.aspx.

  • MLA

    Robertson, Sally. "Defective astrocytes linked to alpha-synuclein accumulation in Parkinson's". News-Medical. 19 October 2019. <https://www.news-medical.net/news/20190110/Defective-astrocytes-linked-to-alpha-synuclein-accumulation-in-Parkinsons.aspx>.

  • Chicago

    Robertson, Sally. "Defective astrocytes linked to alpha-synuclein accumulation in Parkinson's". News-Medical. https://www.news-medical.net/news/20190110/Defective-astrocytes-linked-to-alpha-synuclein-accumulation-in-Parkinsons.aspx. (accessed October 19, 2019).

  • Harvard

    Robertson, Sally. 2019. Defective astrocytes linked to alpha-synuclein accumulation in Parkinson's. News-Medical, viewed 19 October 2019, https://www.news-medical.net/news/20190110/Defective-astrocytes-linked-to-alpha-synuclein-accumulation-in-Parkinsons.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post